Status:
UNKNOWN
Evolution of a Novel Optical Coherence Tomography Based Index in Diagnosing Keratoconus
Lead Sponsor:
Tianjin Eye Hospital
Conditions:
Scansys, Pentacam, Keratoconus, Subclinical Keratoconus
Eligibility:
All Genders
Brief Summary
Comparison of corneal topography based on oct OCT principle (CASIA2) with Pentacam and Scheimpflug-based biomechanical devices (Corvis ST) in screening and diagnosing keratoconus; and evaluation of th...
Eligibility Criteria
Inclusion
- Best corrected visual acuity (BCVA) ≥ 20/20;
- No other eye diseases except myopia and astigmatism;
- The cornea was transparent, and there was no cloud or pannus;
Exclusion
- The presence of ocular diseases other than myopia and keratoconus;
- Ocular trauma;
- Previous ocular surgery; 4 Patients were required to stop wearing soft contact lenses for at least 2 weeks and rigid contact lenses for at least 4 weeks before examination; 6. Pregnant and lactating women;
Key Trial Info
Start Date :
July 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06152484
Start Date
July 1 2023
End Date
April 1 2024
Last Update
November 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tiajin Eye Hospital
Tianjin, Tianjin Municipality, China